கிறிஸ்டன் க்லுஸ்கா கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கிறிஸ்டன் க்லுஸ்கா கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கிறிஸ்டன் க்லுஸ்கா கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட் Today - Breaking & Trending Today

Amicus Therapeutics Inc (FOLD) Q1 2021 Earnings Call Transcript


Operator
Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics First Quarter 2021 Financial Results Conference Call and Webcast. [Operator Instructions]
I would now like to turn the conference over to your host, Mr. Andrew Faughnan, Head of Investor Relations. You may begin.
Andrew Faughnan
Thank you, Mary.
Good morning. Thank you for joining our conference call to discuss Amicus Therapeutics first quarter 2021 financial results and corporate highlights.
Speaking on today s call, we have John Crowley, Chairman and Chief Executive Officer; Bradley Campbell, President and Chief Operating Officer; Daphne Quimi, Chief Financial Officer; and Dr. Jeff Castelli, Chief Development Officer. Joining for Q&A, we ll have Dr. Mitchell Goldman, Senior Vice President of Clinical Research joining. ....

United States , University Of Pennsylvania , Mitchell Goldman , Fisher Brammer , Anupam Rama , Salveen Richter Goldman Sachs , Debjit Chattopadhyay , Mohit Bansal Citigroup , Bradley Campbell , Salveen Richter , Daphne Quimi , Andrew Faughnan , Kristen Kluska , Kristen Kluska Cantor Fitzgerald , Jim Wilson , Sanofi Genzyme , Jeff Castelli , Sebastien Martel , John Crowley , Tessa Romero Jpmorgan , Tazeen Ahmad , Mohit Bansal , Joseph Schwartz , Development Officer , Goldman Sachs , Amicus Therapeutics Inc ,

Amicus Therapeutics Inc (FOLD) Q4 2020 Earnings Call Transcript


Amicus Therapeutics Inc (FOLD) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Amicus Therapeutics Inc (NASDAQ: FOLD)
Popular Searches
Operator
Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics Fourth Quarter 2020 Fiscal Year Results Conference Call and Webcast. [Operator Instructions] I would now like to turn the conference over to your host, Mr. Andrew Faughnan, Head of Investor Relations. You may begin.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please ....

United States , University Of Pennsylvania , Mitchell Goldman , Anupam Rama , Bradleyl Campbell , Henri Termeer , Debjit Chattopadhyay , Mohit Bansal Citigroup , Bradley Campbell , Elizabeth Webster Goldman Sachs , Jeffreyp Castelli , Johnf Crowley , Salveen Richter , Daphne Quimi , Andrew Faughnan , Kristen Kluska , Kristen Kluska Cantor Fitzgerald , Jim Wilson , Aaron Welch Guggenheim , Jeff Castelli , Rossella Passero , Fabry Pompe , Anvita Cowen , John Crowley , Tazeen Ahmad , Mohit Bansal ,